Inflammatory bowel disease in pregnancy.
Fertility is affected in ulcerative colitis after surgery and in active Crohn's disease. Adverse fetal outcomes are not increased when IBD is quiescent. Active disease at conception increases the risk of adverse fetal outcomes. Most medications for IBD are safe during pregnancy and breastfeeding, with notable exceptions. Active disease is usually more deleterious than maintaining medical therapy.
Kane
Sunanda
S
Division of Gastroenterology, Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA. skane@medicine.bsd.uchicago.edu
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D011247:Pregnancy; D011248:Pregnancy Complications
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents